Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Andréa Kazumi Shimada"'
Autor:
Patricia Weinschenker Bollmann, Andréa Kazumi Shimada, Nilceo Schwery Michalany, Ana Rita de Araújo Burgos Manhani, Auro del Giglio
Publikováno v:
Einstein (São Paulo), Vol 9, Iss 2, Pp 212-215 (2011)
The livedoid vasculopathy is a rare condition characterized by the presence of recurrent painful ulcers in distal extremities of lower limbs. Histologically there is thickness of dermal vessels, occlusion of its light by fibrin thrombi associated wit
Externí odkaz:
https://doaj.org/article/7b52b6e0dee242699a5bf768279e5b17
Autor:
Patricia Weinschenker Bollmann, Andréa Kazumi Shimada, Nilceo Schwery Michalany, Ana Rita de Araújo Burgos Manhani, Auro del Giglio
Publikováno v:
Einstein (São Paulo), Vol 9, Iss 2, Pp 212-215 (2011)
The livedoid vasculopathy is a rare condition characterized by thepresence of recurrent painful ulcers in distal extremities of lower limbs. Histologically there is thickness of dermal vessels, occlusion of its light by fibrin thrombi associated with
Externí odkaz:
https://doaj.org/article/62a6dd893b414626930c49b6379e58e8
Autor:
Marcello Moro Queiroz, Karina Perez Sacardo, Mauricio Fernando Ribeiro, Luiza Lara Gadotti, Rodrigo Saddi, Leandro Jonata de Carvalho Oliveira, Rudinei Diogo Marques Linck, Marcelo Rocha de Souza Cruz, Romualdo Barroso-Sousa, Marina Sahade, Tatiana Strava Correa, Max Senna Mano, Daniele Assad Suzuki, Andrea Kazumi Shimada, Artur Katz
Publikováno v:
Cancer Treatment and Research Communications, Vol 35, Iss , Pp 100683- (2023)
Background: Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) have been recently developed and introduced into clinical practice. Methods: We retrospectively analyzed data from patients with confirmed HR+/HER2 metastatic breast cancer treated with hor
Externí odkaz:
https://doaj.org/article/f00841e7cf3c4c4fa3e29cdc2d34613b
Autor:
Leandro Jonata Carvalho Oliveira, Thais Baccili Cury Megid, Daniela Dornelles Rosa, Carlos Alberto da Silva Magliano, Daniele Xavier Assad, Daniel Fontes Argolo, Solange Moraes Sanches, Laura Testa, José Bines, Rafael Kaliks, Maira Caleffi, Debora de Melo Gagliato, Marina Sahade, Romualdo Barroso-Sousa, Tatiana Strava Corrêa, Andrea Kazumi Shimada, Daniel Negrini Batista, Daniel Musse Gomes, Marcelle Goldner Cesca, Débora Gaudêncio, Larissa Matos Almeida Moura, Julio Antonio Pereira de Araújo, Artur Katz, Max Senna Mano
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: Oncotype DX (ODX) is a validated assay for the prediction of risk of recurrence and benefit of chemotherapy (CT) in both node negative (N0) and 1–3 positive nodes (N1), hormone receptor positive (HR+), human epidermal growth factor rece
Externí odkaz:
https://doaj.org/article/bf12e41b48ea42f997e8e48720fed3f0
Autor:
Maurício Fernando Silva Almeida Ribeiro, Franciele Hinterholz Knebel, Fabiana Bettoni, Rodrigo Saddi, Karina Perez Sacardo, Felipe Sales Nogueira Amorim Canedo, João Victor Machado Alessi, Andrea Kazumi Shimada, José Flávio Gomes Marin, Anamaria Aranha Camargo, Artur Katz
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-7 (2021)
Abstract The survival outcomes of the FLAURA trial support osimertinib as the new standard of care for untreated patients harboring activating mutations in the epidermal growth factor receptor (EGFR). Despite the initial response, disease progression
Externí odkaz:
https://doaj.org/article/44561a7f82f943959883dc09c9964b77